Depending on the anatomy of your valve and the severity of your regurgitation, doctors may recommend medications to reduce symptoms and support your heart function. Treatment may include ...

GlobalData analysts anticipate FDA approval for the JenaValve Trilogy TAVR device designed to treat aortic regurgitation (AR) ...

Background Although the prognostic implications of severe mitral regurgitation (MR) are well recognised, they are less clear ...

This condition can affect any of the four heart valves with either valvular stenosis (narrowing) or valvular regurgitation (leakiness and backflow). Valvular heart disease affects about 2.5% of ...

Background Mitral valve repair (MVr) is the gold standard treatment for degenerative mitral regurgitation, yet there is ...

New 20-year data show a survival rate of 90% with few repeat surgeries after this complex operation that can only be ...

The US Food and Drugs Administration (FDA) is expected to approve the JenaValve Trilogy System, a transcatheter aortic valve ...

LOS ANGELES -- Cardiac surgeons were urged to readjust their attitudes toward the tricuspid valve if they want to keep some ...